Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ID Biomedical Corporation
Quebec, Quebec, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
ID Biomedical was a leading influenza vaccine manufacturer that supplied approximately 75% of the Canadian government's influenza vaccine purchases before being acquired by GSK in 2005.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Vaccines
- Industry
- Biotech
02
Partnerships
Government of Canada (ten-year mandate from 2001 to provide influenza vaccine)
Beyond the preview
Go deeper on ID Biomedical Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ID Biomedical Corporation.